VanEck Associates
HUM icon

VanEck Associates’s Humana HUM Stock Holding History

VanEck Associates’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
12,497
-8,828
-41% -$1.81M ﹤0.01% 973
2025
Q4 		$5.46M Buy
21,325
+9,312
+78% +$2.44M ﹤0.01% 755
2025
Q3 		$3.13M Buy
12,013
+8,994
+298% +$2.37M ﹤0.01% 904
2025
Q2 		$738K Sell
3,019
-544
-15% -$136K ﹤0.01% 1104
2025
Q1 		$943K Buy
3,563
+197
+6% +$53.3K ﹤0.01% 1047
2024
Q4 		$854K Buy
3,366
+2,027
+151% +$544K ﹤0.01% 1061
2024
Q3 		$346K Buy
+1,339
New +$477K ﹤0.01% 1128
2024
Q1 		– Sell
-1,512
Closed -$692K – 1391
2023
Q4 		$692K Sell
1,512
-256
-14% -$126K ﹤0.01% 1009
2023
Q3 		$860K Buy
+1,768
New +$831K ﹤0.01% 932
2021
Q3 		– Sell
-1,630
Closed -$722K – 1307
2021
Q2 		$722K Buy
1,630
+64
+4% +$28K ﹤0.01% 856
2021
Q1 		$657K Buy
1,566
+298
+24% +$119K ﹤0.01% 809
2020
Q4 		$520K Buy
1,268
+846
+200% +$352K ﹤0.01% 770
2020
Q3 		$175K Buy
+422
New +$170K ﹤0.01% 833

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

VanEck Associates's HUM Position: Q1 2026 in Review

VanEck Associates reduced its Humana (HUM) stake by 41% in Q1 2026, selling an estimated $1.81M and leaving 12,497 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #973.

VanEck Associates first reported a position in HUM in Q3 2020 and has held it in 13 quarters since. The position peaked at $5.46M in Q4 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • VanEck Associates held 12,497 shares of Humana worth $2.17M as of Q1 2026.
  • VanEck Associates sold 8,828 Humana shares in Q1 2026, an estimated $1.81M.
  • Humana made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #973 holding.
  • VanEck Associates first reported a position in Humana in Q3 2020 and has held it in 13 quarters since.
  • VanEck Associates's Humana position peaked at $5.46M in Q4 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.